Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 28% ± 10% | |
peripheral blood | 18 studies | 37% ± 14% | |
brain | 16 studies | 34% ± 18% | |
intestine | 9 studies | 29% ± 10% | |
eye | 9 studies | 28% ± 8% | |
kidney | 6 studies | 26% ± 6% | |
lymph node | 5 studies | 31% ± 11% | |
liver | 5 studies | 32% ± 13% | |
bone marrow | 4 studies | 38% ± 18% | |
uterus | 4 studies | 40% ± 12% | |
breast | 4 studies | 24% ± 6% | |
pancreas | 3 studies | 54% ± 18% | |
placenta | 3 studies | 22% ± 5% | |
heart | 3 studies | 19% ± 0% | |
adipose | 3 studies | 28% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 9821.99 | 459 / 459 | 100% | 59.40 | 1118 / 1118 |
esophagus | 100% | 7416.31 | 1445 / 1445 | 100% | 55.96 | 183 / 183 |
lung | 100% | 8201.85 | 578 / 578 | 100% | 40.70 | 1155 / 1155 |
ovary | 100% | 12313.12 | 180 / 180 | 100% | 31.25 | 430 / 430 |
prostate | 100% | 9101.90 | 245 / 245 | 100% | 47.96 | 502 / 502 |
uterus | 100% | 11186.37 | 170 / 170 | 100% | 39.65 | 459 / 459 |
thymus | 100% | 9821.72 | 653 / 653 | 100% | 48.25 | 603 / 605 |
brain | 100% | 6254.39 | 2631 / 2642 | 100% | 47.52 | 705 / 705 |
pancreas | 100% | 4700.10 | 328 / 328 | 99% | 32.56 | 177 / 178 |
bladder | 100% | 9188.29 | 21 / 21 | 99% | 36.46 | 499 / 504 |
adrenal gland | 100% | 7318.18 | 258 / 258 | 98% | 36.89 | 226 / 230 |
stomach | 100% | 6261.00 | 359 / 359 | 98% | 44.19 | 281 / 286 |
kidney | 100% | 5262.70 | 89 / 89 | 98% | 31.55 | 884 / 901 |
intestine | 100% | 8234.97 | 966 / 966 | 98% | 40.13 | 515 / 527 |
skin | 100% | 9285.47 | 1809 / 1809 | 95% | 34.72 | 449 / 472 |
liver | 100% | 3435.17 | 226 / 226 | 95% | 16.75 | 384 / 406 |
blood vessel | 100% | 7963.35 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 35.92 | 29 / 29 |
muscle | 100% | 5626.90 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8851.13 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 38.04 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.32 | 1 / 1 |
adipose | 100% | 9152.09 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 4271.42 | 841 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 19.57 | 70 / 80 |
peripheral blood | 86% | 4879.00 | 795 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_0006974 | Biological process | DNA damage response |
GO_2001244 | Biological process | positive regulation of intrinsic apoptotic signaling pathway |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_2000144 | Biological process | positive regulation of DNA-templated transcription initiation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016607 | Cellular component | nuclear speck |
GO_0016592 | Cellular component | mediator complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | BCLAF1 |
Protein name | BCL2 associated transcription factor 1 BCLAF1 protein Bcl-2-associated transcription factor 1 (Btf) (BCLAF1 and THRAP3 family member 1) |
Synonyms | BTF KIAA0164 |
Description | FUNCTION: Death-promoting transcriptional repressor. May be involved in cyclin-D1/CCND1 mRNA stability through the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. . |
Accessions | ENST00000532384.5 ENST00000527613.5 E9PKI6 ENST00000628517.2 Q9NYF8 ENST00000527536.5 ENST00000392348.6 [Q9NYF8-3] ENST00000534269.5 ENST00000530429.5 E9PK09 E9PJA7 ENST00000640069.1 ENST00000531224.6 [Q9NYF8-1] ENST00000529826.5 A0A1W2PQ43 H0YF63 E9PK91 H0YF00 ENST00000533422.5 ENST00000353331.8 [Q9NYF8-3] E9PQN2 ENST00000534762.5 ENST00000533621.1 Q6DCA8 ENST00000527759.5 [Q9NYF8-2] H0YF14 ENST00000530767.5 [Q9NYF8-4] |